Advertisement

Tissue Engineering and Regenerative Medicine

, Volume 16, Issue 2, pp 107–118 | Cite as

Stem Cell-Based Therapies for Liver Diseases: An Overview and Update

  • Jie Wang
  • Meiyan Sun
  • Wei Liu
  • Yan Li
  • Miao LiEmail author
Review Article

Abstract

BACKGROUND:

Liver disease is one of the top causes of death globally. Although liver transplantation is a very effective treatment strategy, the shortage of available donor organs, waiting list mortality, and high costs of surgery remain huge problems. Stem cells are undifferentiated cells that can differentiate into a variety of cell types. Scientists are exploring the possibilities of generating hepatocytes from stem cells as an alternative for the treatment of liver diseases.

METHODS:

In this review, we summarized the updated researches in the field of stem cell-based therapies for liver diseases as well as the current challenges and future expectations for a successful cell-based liver therapy.

RESULTS:

Several cell types have been investigated for liver regeneration, such as embryonic stem cells, induced pluripotent stem cells, liver stem cells, mesenchymal stem cells, and hematopoietic stem cells. In vitro and in vivo studies have demonstrated that stem cells are promising cell sources for the liver regeneration.

CONCLUSION:

Stem cell-based therapy could be a promising therapeutic method for patients with end-stage liver disease, which may alleviate the need for liver transplantation in the future.

Keywords

Stem cells Liver disease Stem cell-based therapy Liver regeneration 

Notes

Acknowledgements

This work was supported by the National Natural Science Fund of the People’s Republic of China (No. 81771304), the National Natural Science Youth Fund of the People’s Republic of China (No. 81601234 and No. 81601073), and the Health Special Fund of Jilin Province, China (SCZSY201616) and the Science and Technology Innovation Development Fund of Jilin (No. 201750246).

Compliance with ethical standards

Conflict of interest

The authors declare that there is no conflict of interest regarding the publication of this paper.

Ethical approval

There are no animal experiments carried out for this article.

References

  1. 1.
    Michalopoulos GK, DeFrances MC. Liver regeneration. Science. 1997;276:60–6.Google Scholar
  2. 2.
    Şentürk Ü, Yücedağ I, Polat K. Repetitive neural network (RNN) based blood pressure estimation using PPG and ECG signals. In 2018 2nd International Symposium on Multidisciplinary Studies and Innovative Technologies (ISMSIT) 2018 Oct 19. IEEE.Google Scholar
  3. 3.
    Song AT, Avelino-Silva VI, Pecora RA, Pugliese V, D’Albuquerque LA, Abdala E. Liver transplantation: fifty years of experience. World J Gastroenterol. 2014;20:5363–74.Google Scholar
  4. 4.
    Soltys KA, Setoyama K, Tafaleng EN, Soto Gutiérrez A, Fong J, Fukumitsu K, et al. Host conditioning and rejection monitoring in hepatocyte transplantation in humans. J Hepatol. 2017;66:987–1000.Google Scholar
  5. 5.
    Forbes SJ, Gupta S, Dhawan A. Cell therapy for liver disease: From liver transplantation to cell factory. J Hepatol. 2015;62:S157–69.Google Scholar
  6. 6.
    Volarevic V, Nurkovic J, Arsenijevic N, Stojkovic M. Concise review: therapeutic potential of mesenchymal stem cells for the treatment of acute liver failure and cirrhosis. Stem cells. 2014;32:2818–23.Google Scholar
  7. 7.
    Trounson A, McDonald C. Stem cell therapies in clinical trials: progress and challenges. Cell Stem Cell. 2015;17:11–22.Google Scholar
  8. 8.
    Lane SW, Williams DA, Watt FM. Modulating the stem cell niche for tissue regeneration. Nat Biotechnol. 2014;32:795–803.Google Scholar
  9. 9.
    Kopp JL, Grompe M, Sander M. Stem cells versus plasticity in liver and pancreas regeneration. Nat Cell Biol. 2016;18:238–45.Google Scholar
  10. 10.
    Katagiri H, Kushida Y, Nojima M, Kuroda Y, Wakao S, Ishida K, et al. A distinct subpopulation of bone marrow mesenchymal stem cells, muse cells, directly commit to the replacement of liver components. Am J Transplant. 2016;16:468–83.Google Scholar
  11. 11.
    Wagers AJ, Weissman IL. Plasticity of adult stem cells. Cell. 2004;116:639–48.Google Scholar
  12. 12.
    Itoh T, Miyajima A. Liver regeneration by stem/progenitor cells. Hepatology. 2014;59:1617–26.Google Scholar
  13. 13.
    Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, et al. Embryonic stem cell lines derived from human blastocysts. Science. 1998;282:1145–7.Google Scholar
  14. 14.
    Evans MJ, Kaufman MH. Establishment in culture of pluripotential cells from mouse embryos. Nature. 1981;292:154–6.Google Scholar
  15. 15.
    Ware CB, Nelson AM, Mecham B, Hesson J, Zhou W, Jonlin EC, et al. Derivation of naive human embryonic stem cells. Proc Natl Acad Sci U S A. 2014;111:4484–9.Google Scholar
  16. 16.
    Kuai XL, Shao N, Lu H, Xiao SD, Zheng Q. Differentiation of nonhuman primate embryonic stem cells into hepatocyte-like cells. J Dig Dis. 2014;15:27–34.Google Scholar
  17. 17.
    Brolén G, Sivertsson L, Björquist P, Eriksson G, Ek M, Semb H, et al. Hepatocyte-like cells derived from human embryonic stem cells specifically via definitive endoderm and a progenitor stage. J Biotechnol. 2010;145:284–94.Google Scholar
  18. 18.
    Woo DH, Kim SK, Lim HJ, Heo J, Park HS, Kang GY, et al. Direct and indirect contribution of human embryonic stem cell–derived hepatocyte-like cells to liver repair in mice. Gastroenterology. 2012;142:602–11.Google Scholar
  19. 19.
    Tolosa L, Caron J, Hannoun Z, Antoni M, López S, Burks D, et al. Transplantation of hESC-derived hepatocytes protects mice from liver injury. Stem Cell Res Ther. 2015;6:246.Google Scholar
  20. 20.
    Wang M, Yang X, Zhang P, Cai L, Yang X, Chen Y, et al. Sustained delivery growth factors with polyethyleneimine-modified nanoparticles promote embryonic stem cells differentiation and liver regeneration. Adv Sci (Weinh). 2016;3:1500393.Google Scholar
  21. 21.
    Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126:663–76.Google Scholar
  22. 22.
    Pettinato G, Wen X, Zhang N. Engineering strategies for the formation of embryoid bodies from human pluripotent stem cells. Stem Cells Dev. 2015;24:1595–609.Google Scholar
  23. 23.
    Ratajczak MZ, Bujko K, Wojakowski W. Stem cells and clinical practice: new advances and challenges at the time of emerging problems with induced pluripotent stem cell therapies. Pol Arch Med Wewn. 2016;126:879–90.Google Scholar
  24. 24.
    Cai J, Zhao Y, Liu Y, Ye F, Song Z, Qin H, et al. Directed differentiation of human embryonic stem cells into functional hepatic cells. Hepatology. 2007;45:1229–39.Google Scholar
  25. 25.
    Noto FK, Duncan SA. Generation of hepatocyte-like cells from human pluripotent stem cells. In: Sell S, editor. Stem Cells Handbook. New York: Humana Press; 2013. p. 139–47.Google Scholar
  26. 26.
    Si-Tayeb K, Noto FK, Nagaoka M, Li J, Battle MA, Duris C, et al. Highly efficient generation of human hepatocyte–like cells from induced pluripotent stem cells. Hepatology. 2010;51:297–305.Google Scholar
  27. 27.
    Hannan NR, Segeritz CP, Touboul T, Vallier L. Production of hepatocyte-like cells from human pluripotent stem cells. Nat Protoc. 2013;8:430–7.Google Scholar
  28. 28.
    Takebe T, Sekine K, Enomura M, Koike H, Kimura M, Ogaeri T, et al. Vascularized and functional human liver from an iPSC-derived organ bud transplant. Nature. 2013;499:481–4.Google Scholar
  29. 29.
    Liu H, Kim Y, Sharkis S, Marchionni L, Jang YY. In vivo liver regeneration potential of human induced pluripotent stem cells from diverse origins. Sci Transl Med. 2011; 3:82ra39.Google Scholar
  30. 30.
    Zhao T, Zhang ZN, Rong Z, Xu Y. Immunogenicity of induced pluripotent stem cells. Nature. 2011;474:212–5.Google Scholar
  31. 31.
    Guha P, Morgan JW, Mostoslavsky G, Rodrigues NP, Boyd AS. Lack of immune response to differentiated cells derived from syngeneic induced pluripotent stem cells. Cell Stem Cell. 2013;12:407–12.Google Scholar
  32. 32.
    Carraro A, Flaibani M, Cillo U, Michelotto L, Magrofuoco E, Buggio M, et al. A combining method to enhance the in vitro differentiation of hepatic precursor cells. Tissue Eng Part C Methods. 2010;16:1543–51.Google Scholar
  33. 33.
    Irudayaswamy A, Muthiah M, Zhou L, Hung H, Jumat NHB, Haque J, et al. Long-term fate of human fetal liver progenitor cells transplanted in injured mouse livers. Stem Cells. 2018;36:103–13.Google Scholar
  34. 34.
    Takase HM, Itoh T, Ino S, Wang T, Koji T, Akira S, et al. FGF7 is a functional niche signal required for stimulation of adult liver progenitor cells that support liver regeneration. Genes Dev. 2013;27:169–81.Google Scholar
  35. 35.
    Lu WY, Bird TG, Boulter L, Tsuchiya A, Cole AM, Hay T, et al. Hepatic progenitor cells of biliary origin with liver repopulation capacity. Nat Cell Biol. 2015;17:971–83.Google Scholar
  36. 36.
    Huch M, Dorrell C, Boj SF, van Es JH, Li VS, van de Wetering M, et al. In vitro expansion of single Lgr5+ liver stem cells induced by Wnt-driven regeneration. Nature. 2013;494:247–50.Google Scholar
  37. 37.
    Huch M, Gehart H, van Boxtel R, Hamer K, Blokzijl F, Verstegen MM, et al. Long-term culture of genome-stable bipotent stem cells from adult human liver. Cell. 2015;160:299–312.Google Scholar
  38. 38.
    Tuan RS, Boland G, Tuli R. Adult mesenchymal stem cells and cell-based tissue engineering. Arthritis Res Ther. 2003;5:32–45.Google Scholar
  39. 39.
    Liu ZJ, Zhuge Y, Velazquez OC. Trafficking and differentiation of mesenchymal stem cells. J Cell Biochem. 2009;106:984–91.Google Scholar
  40. 40.
    Kobolak J, Dinnyes A, Memic A, Khademhosseini A, Mobasheri A. Mesenchymal stem cells: Identification, phenotypic characterization, biological properties and potential for regenerative medicine through biomaterial micro-engineering of their niche. Methods. 2016;99:62–8.Google Scholar
  41. 41.
    Augello A, Kurth TB, De Bari C. Mesenchymal stem cells: a perspective from in vitro cultures to in vivo migration and niches. Eur Cell Mater. 2010;20:121–33.Google Scholar
  42. 42.
    Porada CD, Zanjani ED, Almeida-Porada G. Adult mesenchymal stem cells: a pluripotent population with multiple applications. Curr Stem Cell Res Ther. 2006;1:365–9.Google Scholar
  43. 43.
    Dowidar MF, El-Belbasi HI, Ayoub AG, Rashed LA, Elged DW. Biochemical and molecular studies on bone marrow derived stromal stem cells on liver injuries in rats. Zag Vet J. 2017;45:355–65.Google Scholar
  44. 44.
    Yin L, Zhu Y, Yang J, Ni Y, Zhou Z, Chen Y, et al. Adipose tissue-derived mesenchymal stem cells differentiated into hepatocyte-like cells in vivo and in vitro. Mol Med Rep. 2015;11:1722–32.Google Scholar
  45. 45.
    Lee SK, Lee SC, Kim SJ. A novel cell-free strategy for promoting mouse liver regeneration: utilization of a conditioned medium from adipose-derived stem cells. Hepatol Int. 2015;9:310–20.Google Scholar
  46. 46.
    Salama H, Zekri AR, Medhat E, Al Alim SA, Ahmed OS, Bahnassy AA, et al. Peripheral vein infusion of autologous mesenchymal stem cells in Egyptian HCV-positive patients with end-stage liver disease. Stem Cell Res Ther. 2014;5:70.Google Scholar
  47. 47.
    Wang L, Han Q, Chen H, Wang K, Shan GL, Kong F, et al. Allogeneic bone marrow mesenchymal stem cell transplantation in patients with UDCA-resistant primary biliary cirrhosis. Stem Cells Dev. 2014;23:2482–9.Google Scholar
  48. 48.
    Jang YO, Kim YJ, Baik SK, Kim MY, Eom YW, Cho MY, et al. Histological improvement following administration of autologous bone marrow-derived mesenchymal stem cells for alcoholic cirrhosis: a pilot study. Liver Int. 2014;34:33–41.Google Scholar
  49. 49.
    Gómez-Aristizábal A, Keating A, Davies JE. Mesenchymal stromal cells as supportive cells for hepatocytes. Mol Ther. 2009;17:1504–8.Google Scholar
  50. 50.
    Rebelo SP, Costa R, Silva MM, Marcelino P, Brito C, Alves PM. Three-dimensional co-culture of human hepatocytes and mesenchymal stem cells: improved functionality in long-term bioreactor cultures. J Tissue Eng Regen Med. 2017;11:2034–45.Google Scholar
  51. 51.
    Wang J, Zhu Z, Huang Y, Wang P, Luo Y, Gao Y, et al. The subtype CD200-positive, chorionic mesenchymal stem cells from the placenta promote regeneration of human hepatocytes. Biotechnol Lett. 2014;36:1335–41.Google Scholar
  52. 52.
    Fitzpatrick E, Wu Y, Dhadda P, Hughes RD, Mitry RR, Qin H, et al. Coculture with mesenchymal stem cells results in improved viability and function of human hepatocytes. Cell Transplant. 2015;24:73–83.Google Scholar
  53. 53.
    Lagasse E, Connors H, Al-Dhalimy M, Reitsma M, Dohse M, Osborne L, et al. Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat Med. 2000;6:1229–34.Google Scholar
  54. 54.
    Lehwald N, Duhme C, Wildner M, Kuhn S, Fürst G, Forbes SJ, et al. HGF and SDF-1-mediated mobilization of CD 133+ BMSC for hepatic regeneration following extensive liver resection. Liver Int. 2014;34:89–101.Google Scholar
  55. 55.
    Körbling M, Katz RL, Khanna A, Ruifrok AC, Rondon G, Albitar M, et al. Hepatocytes and epithelial cells of donor origin in recipients of peripheral-blood stem cells. N Engl J Med. 2002;346:738–46.Google Scholar
  56. 56.
    Wan Z, You S, Rong Y, Zhu B, Zhang A, Zang H, et al. CD34+ hematopoietic stem cells mobilization, paralleled with multiple cytokines elevated in patients with HBV-related acute-on-chronic liver failure. Dig Dis Sci. 2013;58:448–57.Google Scholar
  57. 57.
    Kollet O, Shivtiel S, Chen YQ, Suriawinata J, Thung SN, Dabeva MD, et al. HGF, SDF-1, and MMP-9 are involved in stress-induced human CD34+ stem cell recruitment to the liver. J Clin Invest. 2003;112:160–9.Google Scholar
  58. 58.
    Yannaki E, Athanasiou E, Xagorari A, Constantinou V, Batsis I, Kaloyannidis P, et al. G-CSF–primed hematopoietic stem cells or G-CSF per se accelerate recovery and improve survival after liver injury, predominantly by promoting endogenous repair programs. Exp Hematol. 2005;33:108–19.Google Scholar
  59. 59.
    Zekri AR, Salama H, Medhat E, Musa S, Abdel-Haleem H, Ahmed OS, et al. The impact of repeated autologous infusion of haematopoietic stem cells in patients with liver insufficiency. Stem Cell Res Ther. 2015;6:118.Google Scholar
  60. 60.
    Jang YY, Collector MI, Baylin SB, Diehl AM, Sharkis SJ. Hematopoietic stem cells convert into liver cells within days without fusion. Nat Cell Biol. 2004;6:532–9.Google Scholar
  61. 61.
    Newsome PN, Johannessen I, Boyle S, Dalakas E, McAulay KA, Samuel K, et al. Human cord blood-derived cells can differentiate into hepatocytes in the mouse liver with no evidence of cellular fusion. Gastroenterology. 2003;124:1891–900.Google Scholar
  62. 62.
    Vassilopoulos G, Wang PR, Russell DW. Transplanted bone marrow regenerates liver by cell fusion. Nature. 2003;422:901–4.Google Scholar
  63. 63.
    Alison MR, Poulsom R, Jeffery R, Dhillon AP, Quaglia A, Jacob J, et al. Cell differentiation: hepatocytes from non-hepatic adult stem cells. Nature. 2000;406:257.Google Scholar
  64. 64.
    Martínez Sarrà E. Characterization of dental pulp pluripotent-like stem cells (DPPSC) and their mesodermal differentiation potential. Doctoral dissertation, Universitat Internacional de Catalunya, Barcelona; 2017.Google Scholar
  65. 65.
    Gil Recio C. Obtaining hepatocyte-like cells from dental pulppluripotent-like stem cells. Doctoral dissertation, Universitat Internacional de Catalunya, Barcelona; 2015.Google Scholar
  66. 66.
    Fairhall EA, Wallace K, White SA, Huang GC, Shaw JA, Wright SC, et al. Adult human exocrine pancreas differentiation to hepatocytes–potential source of a human hepatocyte progenitor for use in toxicology research. Toxicol Res (Camb). 2013;2:80–7.Google Scholar
  67. 67.
    Probert PM, Chung GW, Cockell SJ, Agius L, Mosesso P, White SA, et al. Utility of B-13 progenitor-derived hepatocytes in hepatotoxicity and genotoxicity studies. Toxicol Sci. 2014;137:350–70.Google Scholar
  68. 68.
    Wang RY, Shen CN, Lin MH, Tosh D, Shih C. Hepatocyte-like cells transdifferentiated from a pancreatic origin can support replication of hepatitis B virus. J Virol. 2005;79:13116–28.Google Scholar
  69. 69.
    Wallace K, Fairhall EA, Charlton KA, Wright MC. AR42J-B-13 cell: an expandable progenitor to generate an unlimited supply of functional hepatocytes. Toxicology. 2010;278:277–87.Google Scholar
  70. 70.
    Rong Z, Wang M, Hu Z, Stradner M, Zhu S, Kong H, et al. An effective approach to prevent immune rejection of human ESC-derived allografts. Cell Stem Cell. 2014;14:121–30.Google Scholar
  71. 71.
    Hynes RO. US policies on human embryonic stem cells. Nat Rev Mol Cell Biol. 2008;9:993–7.Google Scholar
  72. 72.
    Poulsom R, Alison MR, Forbes SJ, Wright NA. Adult stem cell plasticity. J Pathol. 2002;197:441–56.Google Scholar
  73. 73.
    Wang Y, Zhang Z, Chi Y, Zhang Q, Xu F, Yang Z, et al. Long-term cultured mesenchymal stem cells frequently develop genomic mutations but do not undergo malignant transformation. Cell Death Dis. 2013;4:e950.Google Scholar
  74. 74.
    Oishi K, Noguchi H, Yukawa H, Hayashi S. Differential ability of somatic stem cells. Cell Transplant. 2009;18:581–9.Google Scholar
  75. 75.
    Cawthorn WP, Scheller EL, MacDougald OA. Adipose tissue stem cells meet preadipocyte commitment: going back to the future. J Lipid Res. 2012;53:227–46.Google Scholar
  76. 76.
    Touboul T, Hannan NR, Corbineau S, Martinez A, Martinet C, Branchereau S, et al. Generation of functional hepatocytes from human embryonic stem cells under chemically defined conditions that recapitulate liver development. Hepatology. 2010;51:1754–65.Google Scholar
  77. 77.
    Siller R, Greenhough S, Naumovska E, Sullivan GJ. Small-molecule-driven hepatocyte differentiation of human pluripotent stem cells. Stem cell Reports. 2015;4:939–52.Google Scholar
  78. 78.
    Toivonen S, Lundin K, Balboa D, Ustinov J, Tamminen K, Palgi J, et al. Activin A and Wnt-dependent specification of human definitive endoderm cells. Exp Cell Res. 2013;319:2535–44.Google Scholar
  79. 79.
    Borowiak M, Maehr R, Chen S, Chen AE, Tang W, Fox JL, et al. Small molecules efficiently direct endodermal differentiation of mouse and human embryonic stem cells. Cell Stem Cell. 2009;4:348–58.Google Scholar
  80. 80.
    Takayama K, Inamura M, Kawabata K, Katayama K, Higuchi M, Tashiro K, et al. Efficient generation of functional hepatocytes from human embryonic stem cells and induced pluripotent stem cells by HNF4α transduction. Mol Ther. 2012;20:127–37.Google Scholar
  81. 81.
    Zhou M, Li P, Tan L, Qu S, Ying QL, Song H. Differentiation of mouse embryonic stem cells into hepatocytes induced by a combination of cytokines and sodium butyrate. J Cell Biochem. 2010;109:606–14.Google Scholar
  82. 82.
    Du C, Feng Y, Qiu D, Xu Y, Pang M, Cai N, et al. Highly efficient and expedited hepatic differentiation from human pluripotent stem cells by pure small-molecule cocktails. Stem Cell Res Ther. 2018;9:58.Google Scholar
  83. 83.
    Baxter M, Withey S, Harrison S, Segeritz CP, Zhang F, Atkinson-Dell R, et al. Phenotypic and functional analyses show stem cell-derived hepatocyte-like cells better mimic fetal rather than adult hepatocytes. J Hepatol. 2015;62:581–9.Google Scholar
  84. 84.
    Schwartz RE, Fleming HE, Khetani SR, Bhatia SN. Pluripotent stem cell-derived hepatocyte-like cells. Biotechnol Adv. 2014;32:504–13.Google Scholar
  85. 85.
    Meng Q. Three-dimensional culture of hepatocytes for prediction of drug-induced hepatotoxicity. Expert Opin Drug Metab Toxicol. 2010;6:733–46.Google Scholar
  86. 86.
    Nath S, Devi GR. Three-dimensional culture systems in cancer research: Focus on tumor spheroid model. Pharmacol Ther. 2016;163:94–108.Google Scholar
  87. 87.
    Shamir ER, Ewald AJ. Three-dimensional organotypic culture: experimental models of mammalian biology and disease. Nat Rev Mol Cell Biol. 2014;15:647–64.Google Scholar
  88. 88.
    Kim SE, An SY, Woo DH, Han J, Kim JH, Jang YJ, et al. Engraftment potential of spheroid-forming hepatic endoderm derived from human embryonic stem cells. Stem Cells Dev. 2013;22:1818–29.Google Scholar
  89. 89.
    Ravi M, Paramesh V, Kaviya SR, Anuradha E, Solomon FP. 3D cell culture systems: advantages and applications. J Cell Physiol. 2015;230:16–26.Google Scholar
  90. 90.
    Kim JH, Jang YJ, An SY, Son J, Lee J, Lee G, et al. Enhanced metabolizing activity of human ES cell-derived hepatocytes using a 3D culture system with repeated exposures to xenobiotics. Toxicol Sci. 2015;147:190–206.Google Scholar
  91. 91.
    Ramaiahgari SC, den Braver MW, Herpers B, Terpstra V, Commandeur JN, van de Water B, et al. A 3D in vitro model of differentiated HepG2 cell spheroids with improved liver-like properties for repeated dose high-throughput toxicity studies. Arch Toxicol. 2014;88:1083–95.Google Scholar
  92. 92.
    Cipriano M, Freyer N, Knöspel F, Oliveira NG, Barcia R, Cruz PE, et al. Self-assembled 3D spheroids and hollow-fibre bioreactors improve MSC-derived hepatocyte-like cell maturation in vitro. Arch Toxicol. 2017;91:1815–32.Google Scholar
  93. 93.
    Garnier D, Li R, Delbos F, Fourrier A, Collet C, Guguen-Guillouzo C, et al. Expansion of human primary hepatocytes in vitro through their amplification as liver progenitors in a 3D organoid system. Sci Rep. 2018;8:8222.Google Scholar
  94. 94.
    Vosough M, Omidinia E, Kadivar M, Shokrgozar MA, Pournasr B, Aghdami N, et al. Generation of functional hepatocyte-like cells from human pluripotent stem cells in a scalable suspension culture. Stem Cells Dev. 2013;22:2693–705.Google Scholar
  95. 95.
    Kang A, Park J, Ju J, Jeong GS, Lee SH. Cell encapsulation via microtechnologies. Biomaterials. 2014;35:2651–63.Google Scholar
  96. 96.
    Hashemi M, Kalalinia F. Application of encapsulation technology in stem cell therapy. Life Sci. 2015;143:139–46.Google Scholar
  97. 97.
    Meier RP, Montanari E, Morel P, Pimenta J, Schuurman HJ, Wandrey C, et al. Microencapsulation of hepatocytes and mesenchymal stem cells for therapeutic applications. Methods Mol Biol. 2017;1506:259–71.Google Scholar
  98. 98.
    Meier RP, Mahou R, Morel P, Meyer J, Montanari E, Muller YD, et al. Microencapsulated human mesenchymal stem cells decrease liver fibrosis in mice. J Hepatol. 2015;62:634–41.Google Scholar
  99. 99.
    Hu AB, Cai JY, Zheng QC, He XQ, Shan Y, Pan YL, et al. High-ratio differentiation of embryonic stem cells into hepatocytes in vitro. Liver Int. 2004;24:237–45.Google Scholar
  100. 100.
    Duan Y, Catana A, Meng Y, Yamamoto N, He S, Gupta S, et al. Differentiation and enrichment of hepatocyte-like cells from human embryonic stem cells in vitro and in vivo. Stem Cells. 2007;25:3058–68.Google Scholar
  101. 101.
    Kuai XL, Bian YH, Cong XQ, Li XL, Xiao SD. Differentiation of mouse embryonic stem cells into hepatocytes in vitro and in vivo. J Dig Dis. 2003;4:75–80.Google Scholar
  102. 102.
    Choi D, Oh HJ, Chang UJ, Koo SK, Jiang JX, Hwang SY, et al. In vivo differentiation of mouse embryonic stem cells into hepatocytes. Cell Transplant. 2002;11:359–68.Google Scholar
  103. 103.
    Kharaziha P, Hellström PM, Noorinayer B, Farzaneh F, Aghajani K, Jafari F, et al. Improvement of liver function in liver cirrhosis patients after autologous mesenchymal stem cell injection: a phase I-II clinical trial. Eur J Gastroenterol Hepatol. 2009;21:1199–205.Google Scholar
  104. 104.
    Sakai Y, Takamura M, Seki A, Sunagozaka H, Terashima T, Komura T, et al. Phase I clinical study of liver regenerative therapy for cirrhosis by intrahepatic arterial infusion of freshly isolated autologous adipose tissue-derived stromal/stem (regenerative) cell. Regen Ther. 2017;6:52–64.Google Scholar
  105. 105.
    Shi M, Liu Z, Wang Y, Xu R, Sun Y, Zhang M, et al. A pilot study of mesenchymal stem cell therapy for acute liver allograft rejection. Stem Cells Transl Med. 2017;6:2053–61.Google Scholar
  106. 106.
    El-Ansary M, Abdel-Aziz I, Mogawer S, Abdel-Hamid S, Hammam O, Teaema S, et al. Phase II trial: undifferentiated versus differentiated autologous mesenchymal stem cells transplantation in Egyptian patients with HCV induced liver cirrhosis. Stem Cell Rev. 2012;8:972–81.Google Scholar

Copyright information

© The Korean Tissue Engineering and Regenerative Medicine Society and Springer Nature B.V. 2019

Authors and Affiliations

  • Jie Wang
    • 1
  • Meiyan Sun
    • 2
  • Wei Liu
    • 2
  • Yan Li
    • 2
  • Miao Li
    • 3
    Email author
  1. 1.Department of NeurologyThe China-Japan Union Hospital of Jilin UniversityChangchunChina
  2. 2.Medical Examination CollegeJilin Medical UniversityChangchun, JilinChina
  3. 3.Department of NeurosurgeryThe China-Japan Union Hospital of Jilin UniversityChangchunChina

Personalised recommendations